Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPN-375 in Chronic Sinusitis with or without Nasal Polyps
NCT01623310Phase 3Completed
- Sponsor
- OptiNose
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fluticasone propionate in sinusitis and nasal polyps, sponsored by OptiNose. Primary endpoint: Adverse Events at 12 months. Started Sep 2013; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
sinusitisnasal polyps
Beyond the preview
Go deeper on NCT01623310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623310.